M Ventures Strategic VC arm of Merck backing biotech, tools, electronics, and healthtech.
Amsterdam, Netherlands ●
Corporate VC
National Institutes of Health US federal funder of biomedical and neuroscience research.
Bethesda, United States ●
Non-dilutive
National Science Foundation (NSF) US federal science agency providing non-dilutive SBIR/STTR funding to early-stage neurotech startups.
Alexandria, United States ●
Non-dilutive
NDI Neuro Device Innovations Hybrid investor and builder focused on neurodevice commercialisation.
Cleveland, United States ●
Venture studio
NeuroTechnology Investors Physician-led network investing in medtech and neurotech startups.
Palo Alto, United States ●
Angel investor
Nexus NeuroTech Ventures Venture studio and seed investor dedicated to brain disorder technologies.
San Francisco, United States ●
Venture studio
Noetic Fund Seed investor focused on mental health, CNS, and wellbeing technologies.
Toronto, Canada ●
Venture capital
Norwest Large multi-stage VC with healthcare portfolio including mental health and digital therapeutics.
Palo Alto, United States ●
Venture capital
Octopus Ventures Large UK-based generalist VC with active investments in digital mental health and brain monitoring.
London, United Kingdom ●
Venture capital
One Mind Accelerator Mental health and neurotech accelerator supporting early-stage founders with funding, mentorship, and ecosystem access.
Menlo Park, United States ●
Accelerator/incubator
OrbiMed Global healthcare investment firm across venture, growth, and public markets.
New York, United States ●
Private equity/growth
OSF Innovation Corporate VC arm of OSF Healthcare backing medtech and digital health.
Peoria, United States ●
Corporate VC
OS Fund Deep-tech seed investor backing companies that 'rewrite the operating systems of life'.
Jackson, United States ●
Venture capital
Ottobock Strategic medtech investor in bionics, prosthetics, and neurotechnology.
Duderstadt, Germany ●
Corporate VC
OurCrowd Global investment platform backing startups across healthcare and deep tech.
Oxford Science Enterprises (OSE) Venture investor commercialising Oxford research into science-based companies.
Oxford, United Kingdom ●
Venture capital
Palo Santo Chicago-based venture fund dedicated to psychedelic therapeutics and CNS disorder treatments.
Chicago, United States ●
Venture capital
Panakes Partners European life sciences VC investing in medtech, biotech, and diagnostics.
Milan, Lombardy, Italy ●
Venture capital
Parkwalk Advisors UK VC focused on university spin-outs in deep tech and life sciences.
London, United Kingdom ●
Venture capital
Peter Zhegin (e184) Neurotech-focused investor and field builder associated with e184.
Grand Cayman, Cayman Islands ●
Venture capital
Prime Movers Lab Early-stage investor in breakthrough science and human augmentation technologies.
Jackson, United States ●
Venture capital
PsyMed Ventures Early-stage fund focused on mental health, psychedelics, and neurotechnology.
San Francisco, United States ●
Venture capital
RA Capital Management Multi-stage healthcare investment firm across biotech, devices, and diagnostics.
Boston, United States ●
Private equity/growth
Reeve Foundation Leading SCI nonprofit and venture philanthropy pioneer funding neurotech and spinal cord injury treatments.
Short Hills, United States ●
Other
re.Mind Capital Seed investor focused on mental health, neurological health, and BCI.
Liverpool, United Kingdom ●
Venture capital
Rock Health Seed investor and research platform focused on digital health startups.
San Francisco, United States ●
Venture capital
S32 Sunnyvale-based venture capital firm investing at the frontiers of technology, founded by Bill Maris, with neurotech portfolio.
Sunnyvale, United States ●
Venture capital
Samsung Next Corporate venture investor across AI, healthtech, semiconductors, and wearables.
Seoul, South Korea ●
Corporate VC
Sanofi Ventures Pharma CVC backing early-stage biotech and digital health including neurodegeneration.
Paris, France ●
Corporate VC
SBRI Healthcare UK NHS innovation funding body providing non-dilutive SBRI contracts to health technology companies.
London, United Kingdom ●
Non-dilutive
Sequoia Capital Global venture firm investing from seed to growth across technology and healthcare.
Menlo Park, United States ●
Venture capital
Sofinnova Partners Leading European life sciences VC investing from seed to growth.
Paris, France ●
Venture capital
Sony Innovation Fund Sony’s corporate fund backing strategic technology and health innovation startups.
Tokyo, Japan ●
Corporate VC
Steadview Capital Growth-stage technology investor with selective healthcare and neurotech co-investments.
London, United Kingdom ●
Venture capital
SV Health Investors Healthcare VC with venture, growth, and dementia-focused investment strategies.
Boston, United States ●
Venture capital
Tether Evo Strategic investor in emerging technologies, including neurotech and human augmentation.
London, United Kingdom ●
Venture capital
The Engine (MIT) Tough-tech investor and platform supporting hard science companies from seed stage.
Cambridge, United States ●
Accelerator/incubator
Threshold Ventures Venture firm investing in early-stage tech and selected healthcare companies.
Palo Alto, United States ●
Venture capital
TIME BioVentures Series A investor in healthcare, life sciences, diagnostics, and devices.
Los Angeles, United States ●
Venture capital
Treo Ventures VC focused on Series A/B medtech and digital health companies.
Santa Clara, United States ●
Venture capital
TruVenturo Hamburg-based entrepreneurial investor and company builder that scales early-stage digital and life science startups with a focus on longevity and neurotechnology.
Hamburg, Germany ●
Venture capital
UCL Technology Fund Fund backing commercialisation of University College London research.
London, United Kingdom ●
Other
Venture Kick Swiss pre-seed support platform offering staged funding and coaching.
Zurich, Switzerland ●
Accelerator/incubator
Vertex Growth Growth-stage VC with active investment in neuromodulation.
San Francisco, United States ●
Venture capital
Verve Ventures European VC investing in deep-tech and health from seed to Series C.
Zug, Switzerland ●
Venture capital
Vinnova Sweden's innovation agency providing non-dilutive grants to neurotech and health innovation companies.
Stockholm, Sweden ●
Non-dilutive
Vsquared Ventures Early-stage deep-tech VC backing frontier science, including neuroelectronics.
Munich, Germany ●
Venture capital
Wittington Ventures Canadian family office and CVC backing healthcare innovation including brain health.
Toronto, Canada ●
Family office
Wyss Center Non-dilutive neurotechnology translation centre supporting clinical development.
Geneva, Switzerland ●
Non-dilutive
Xontogeny Early-stage life sciences investor and accelerator with operational support.
Boston, United States ●
Accelerator/incubator
Y Combinator Top startup accelerator and seed investor across all sectors, including neurotech.
Mountain View, United States ●
Accelerator/incubator
Zürcher Kantonalbank Swiss cantonal bank with venture activity in high-tech and life sciences.
Zurich, Switzerland ●
Other
.svg)
.svg)
.svg)
